Junling Wang1, Yanru Qiao2, Christina A Spivey3, Christine Li4, Caroline Clark5, Yuewen Deng6, Flora Liu7, Jeffrey Tillman8, Marie Chisholm-Burns9. 1. Department of Clinical Pharmacy, The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Room 221, Memphis, TN 38163. 2. Department of Clinical Pharmacy, The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Room 212, Memphis, TN 38163, , , yqiao1@uthsc.edu. 3. Department of Clinical Pharmacy, The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Room 258, Memphis, TN 38163, , , cspivey3@uthsc.edu. 4. The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Memphis, TN 38163, , , cli25@uthsc.edu. 5. The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Memphis, TN 38163, , , carolee92@gmail.com. 6. The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Memphis TN 38163, , , ywdeng3@gmail.com. 7. Firefly Life Technologies, 101 Catskill Court, Belle Mead, NJ 08502, , , fliu9327@gmail.com. 8. The University of Tennessee Health Science Center, 881 Madison Avenue, Memphis TN 38163, , , jtillma3@uthsc.edu. 9. The University of Tennessee Health Science Center, 881 Madison Avenue, Memphis TN 38139, , , mchisho3@uthsc.edu.
Abstract
OBJECTIVES: Previous studies found that racial and ethnic minorities may be less likely than non-Hispanic Whites (Whites) to meet existing Medicare medication therapy management (MTM) eligibility criteria. To address these issues, the Centers for Medicare & Medicaid Services (CMS) proposed alternative Medicare MTM eligibility criteria for 2015. Due to opposition to other Part D reforms proposed simultaneously by various stakeholders, CMS rescinded all proposed reforms. This study was conducted to determine whether non-Hispanic Blacks (Blacks) and Hispanics have lower likelihood of meeting the proposed 2015 Medicare MTM eligibility criteria. METHODS: This retrospective observational analysis used Medical Expenditure Panel Survey data (2010-2011). The final study sample was comprised of 2,721 Whites (weighted to 37,185,896), 917 Blacks (weighted to 4,665,644), and 538 Hispanics (weighted to 3,532,882). Chi-square tests were used to examine racial and ethnic disparities in meeting proposed 2015 MTM eligibility criteria and each component of proposed 2015 MTM eligibility criteria. In multivariate analysis, a logistic regression model was used to control for population socio-demographic and health-related characteristics. KEY FINDINGS: Compared to Whites with a proportion of MTM eligibility of 58.82%, the eligible proportion was 57.09% (P=0.20) for Blacks, and 48.97% (P<0.0001) for Hispanics, respectively. According to multivariate logistic regression, odds ratios of meeting MTM eligibility for Blacks and Hispanics compared to Whites were 0.74 (95% Confidence Internal [CI] = 0.62-0.88) and 0.53 (95% CI=0.43-0.67), respectively. CONCLUSIONS: The proposed 2015 MTM eligibility criteria would not eliminate racial and ethnic disparities in MTM eligibility. Alternative MTM eligibility criteria should be devised.
OBJECTIVES: Previous studies found that racial and ethnic minorities may be less likely than non-Hispanic Whites (Whites) to meet existing Medicare medication therapy management (MTM) eligibility criteria. To address these issues, the Centers for Medicare & Medicaid Services (CMS) proposed alternative Medicare MTM eligibility criteria for 2015. Due to opposition to other Part D reforms proposed simultaneously by various stakeholders, CMS rescinded all proposed reforms. This study was conducted to determine whether non-Hispanic Blacks (Blacks) and Hispanics have lower likelihood of meeting the proposed 2015 Medicare MTM eligibility criteria. METHODS: This retrospective observational analysis used Medical Expenditure Panel Survey data (2010-2011). The final study sample was comprised of 2,721 Whites (weighted to 37,185,896), 917 Blacks (weighted to 4,665,644), and 538 Hispanics (weighted to 3,532,882). Chi-square tests were used to examine racial and ethnic disparities in meeting proposed 2015 MTM eligibility criteria and each component of proposed 2015 MTM eligibility criteria. In multivariate analysis, a logistic regression model was used to control for population socio-demographic and health-related characteristics. KEY FINDINGS: Compared to Whites with a proportion of MTM eligibility of 58.82%, the eligible proportion was 57.09% (P=0.20) for Blacks, and 48.97% (P<0.0001) for Hispanics, respectively. According to multivariate logistic regression, odds ratios of meeting MTM eligibility for Blacks and Hispanics compared to Whites were 0.74 (95% Confidence Internal [CI] = 0.62-0.88) and 0.53 (95% CI=0.43-0.67), respectively. CONCLUSIONS: The proposed 2015 MTM eligibility criteria would not eliminate racial and ethnic disparities in MTM eligibility. Alternative MTM eligibility criteria should be devised.
Authors: Junling Wang; Jason M Noel; Ilene H Zuckerman; Nancy A Miller; Fadia T Shaya; C Daniel Mullins Journal: Med Care Res Rev Date: 2006-12 Impact factor: 3.929
Authors: Stephen B Thomas; Sandra Crouse Quinn; James Butler; Craig S Fryer; Mary A Garza Journal: Annu Rev Public Health Date: 2011 Impact factor: 21.981
Authors: Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman Journal: Res Social Adm Pharm Date: 2013-06-10
Authors: Kiraat D Munshi; Ya-Chen T Shih; Lawrence M Brown; Samuel Dagogo-Jack; Jim Y Wan; Junling Wang Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2013-04 Impact factor: 2.217
Authors: Christina A Spivey; Yanru Qiao; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Marie A Chisholm-Burns Journal: J Am Geriatr Soc Date: 2019-01-23 Impact factor: 5.562
Authors: Xiaobei Dong; Chi Chun Steve Tsang; Shirong Zhao; Jim Y Wan; Ya-Chen Tina Shih; Marie A Chisholm-Burns; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Junling Wang Journal: Am Health Drug Benefits Date: 2021-09
Authors: Jamie A Browning; Chi Chun Steve Tsang; Rose Zeng; Xiaobei Dong; Joseph Garuccio; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Junling Wang Journal: Curr Med Res Opin Date: 2022-08-09 Impact factor: 2.705
Authors: Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: J Pharm Health Serv Res Date: 2018-09-07
Authors: Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie A Chisholm-Burns Journal: Inquiry Date: 2018 Jan-Dec Impact factor: 1.730
Authors: Jamie A Browning; Chi Chun Steve Tsang; Xiaobei Dong; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Colin Liu; Junling Wang Journal: BMC Health Serv Res Date: 2022-02-07 Impact factor: 2.655
Authors: Christina A Spivey; Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: J Manag Care Spec Pharm Date: 2018-02